Moreover, finding new molecules that can act via TREML-1 could modulate the activity of TREM-2, and vice-versa On the other hand, also targeting TREML-2 could open to new strategies for the treatment of Alzheimer’s disease, highly enhancing the rate of success. The gene discussed is TREML1; the disease is early-onset autosomal dominant Alzheimer disease.